Cyclosporine Plus Methotrexate or Alemtuzumab

Clinical trial NCT02701517 · TERMINATED

Trial details

NCT number: NCT02701517
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Unrecognized Condition: Mature B or T-cell Neoplasm

Start date: 2003-09-01
Primary completion: 2009-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.